<DOC>
	<DOCNO>NCT01738217</DOCNO>
	<brief_summary>This prospective , monocentric , non-randomized , phase I-II study . The goal ass faisability capability fluorescence image hepatic surgery , specially help surgeon perform liver surgery . This study perform patient intend undergo liver cancer surgery.It contain three step , assess follow item : - Step 1 : ass faisability use Fluobeam , actual clinical surgical condition validate data obtain preclinical phase , - Step 2 : ass ability combination ICG Fluobeam mark hepatic lesion , - Step 3 : ass ability combination ICG Fluobeam help guide per-hepatectomy . 3 6 patient enrol first step , 20 second step 20 third step . Patients follow 4 week surgery .</brief_summary>
	<brief_title>Assessment Indocyanine Green Near-Infrared Fluorescent Contrast Agent Image-guided Liver Surgery</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Adult patient Affected hepatic cancerous lesion whatever Requiring one two step hepatectomy laparotomy ECOG performance status ( PS ) â‰¤ 2 Mandatory affiliation health security insurance Written inform consent With contraindication hypersensitivity ICG administration medical history Having already undergone major hepatic surgery ( three segment ) major biliar surgery ( context major iterative hepatic surgery ) Unable follow duration study , social , family , geographical psychological reason Pregnant breastfeed woman ( urinary strip must negative time inclusion study woman age procreate )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Intra-operative imaging</keyword>
	<keyword>NIR Fluorescence</keyword>
	<keyword>Liver surgery</keyword>
	<keyword>Tumoral margin</keyword>
</DOC>